Ensign Peak Advisors’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Hold |
29,111
| – | – | ﹤0.01% | 1556 |
|
|
2025
Q1 | $569K | Hold |
29,111
| – | – | ﹤0.01% | 1514 |
|
|
2024
Q4 | $722K | Hold |
29,111
| – | – | ﹤0.01% | 1485 |
|
|
2024
Q3 | $713K | Hold |
29,111
| – | – | ﹤0.01% | 1498 |
|
|
2024
Q2 | $682K | Hold |
29,111
| – | – | ﹤0.01% | 1502 |
|
|
2024
Q1 | $962K | Sell |
29,111
-1,469
| -5% | -$48.5K | ﹤0.01% | 1349 |
|
|
2023
Q4 | $832K | Hold |
30,580
| – | – | ﹤0.01% | 1483 |
|
|
2023
Q3 | $735K | Hold |
30,580
| – | – | ﹤0.01% | 1419 |
|
|
2023
Q2 | $976K | Buy |
30,580
+2,250
| +8% | +$71.8K | ﹤0.01% | 1279 |
|
|
2023
Q1 | $867K | Buy |
28,330
+2,800
| +11% | +$85.7K | ﹤0.01% | 1352 |
|
|
2022
Q4 | $998K | Buy |
25,530
+11,800
| +86% | +$461K | ﹤0.01% | 1160 |
|
|
2022
Q3 | $654K | Sell |
13,730
-60,757
| -82% | -$2.89M | ﹤0.01% | 1322 |
|
|
2022
Q2 | $2.88M | Buy |
74,487
+66,047
| +783% | +$2.56M | 0.01% | 685 |
|
|
2022
Q1 | $484K | Hold |
8,440
| – | – | ﹤0.01% | 1562 |
|
|
2021
Q4 | $673K | Sell |
8,440
-18,594
| -69% | -$1.48M | ﹤0.01% | 1486 |
|
|
2021
Q3 | $2.35M | Hold |
27,034
| – | – | ﹤0.01% | 1020 |
|
|
2021
Q2 | $3.48M | Hold |
27,034
| – | – | 0.01% | 807 |
|
|
2021
Q1 | $2.16M | Sell |
27,034
-93,273
| -78% | -$7.47M | ﹤0.01% | 1073 |
|
|
2020
Q4 | $9.82M | Buy |
120,307
+54,489
| +83% | +$4.45M | 0.02% | 422 |
|
|
2020
Q3 | $1.62M | Buy |
65,818
+37,366
| +131% | +$919K | ﹤0.01% | 1084 |
|
|
2020
Q2 | $797K | Sell |
28,452
-6,154
| -18% | -$172K | ﹤0.01% | 1347 |
|
|
2020
Q1 | $623K | Buy |
+34,606
| New | +$623K | ﹤0.01% | 1328 |
|